Valeant Pharmaceuticals International Senior Developer Salaries in Baltimore, MD
The average Valeant Pharmaceuticals International Senior Developer in Baltimore, MD earns an estimated $120,503 annually, which includes an estimated base salary of $111,380 with a $9,123 bonus. Valeant Pharmaceuticals International's Senior Developer compensation is $17,197 less than the US average for a Senior Developer. Senior Developer salaries at Valeant Pharmaceuticals International in Baltimore, MD can range from $75,000 - $187,200.
In Baltimore, MD, The Engineering Department at Valeant Pharmaceuticals International earns $3,057 more on average than the Design Department.
Last updated 3 years ago.
- $111,380
- avg. base
- $9,123
- avg. bonus
Senior Developer Salaries at Valeant Pharmaceuticals International
In Baltimore, MD, Senior Developers earn $4,492 more than Senior Developers, and $1,573 less than Lead Engineers.
Compensation at Valeant Pharmaceuticals International by Department
In Baltimore, MD, The Engineering Department averages $3,057 more than the Design Department, and $3,709 less than the HR Department
Senior Developer Compensation by Gender (All Companies)
The average female Senior Developer at companies similar size to Valeant Pharmaceuticals International reported making $146,554, while the average male Senior Developer at similar sized companies reported making $156,727.
Senior Developer Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Senior Developer at companies similar size to Valeant Pharmaceuticals International reported making $153,064, while the average Native American Senior Developer at similar sized companies reported making $101,264.
How Senior Developers at Valeant Pharmaceuticals International Rate Their Compensation
The majority of Senior Developers at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Senior Developers at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
